GYL Financial Synergies’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $8.28M | Sell |
286,180
-43,089
| -13% | -$1.25M | 0.62% | 38 |
|
2024
Q2 | $9.21M | Sell |
329,269
-8,434
| -2% | -$236K | 0.71% | 34 |
|
2024
Q1 | $9.37M | Sell |
337,703
-39,306
| -10% | -$1.09M | 0.73% | 36 |
|
2023
Q4 | $10.9M | Buy |
377,009
+23,251
| +7% | +$669K | 0.9% | 26 |
|
2023
Q3 | $11.7M | Buy |
353,758
+8,263
| +2% | +$274K | 1.14% | 17 |
|
2023
Q2 | $12.7M | Buy |
345,495
+79,726
| +30% | +$2.92M | 1.15% | 19 |
|
2023
Q1 | $10.8M | Buy |
265,769
+242,308
| +1,033% | +$9.89M | 1.3% | 20 |
|
2022
Q4 | $1.2M | Buy |
23,461
+1,634
| +7% | +$83.7K | 0.26% | 63 |
|
2022
Q3 | $955K | Buy |
21,827
+14
| +0.1% | +$613 | 0.26% | 59 |
|
2022
Q2 | $1.14M | Buy |
21,813
+3,812
| +21% | +$200K | 0.31% | 51 |
|
2022
Q1 | $932K | Sell |
18,001
-3,618
| -17% | -$187K | 0.22% | 58 |
|
2021
Q4 | $1.28M | Buy |
21,619
+1,302
| +6% | +$76.9K | 0.34% | 48 |
|
2021
Q3 | $874K | Buy |
20,317
+2,743
| +16% | +$118K | 0.45% | 53 |
|
2021
Q2 | $688K | Sell |
17,574
-114
| -0.6% | -$4.46K | 0.36% | 68 |
|
2021
Q1 | $641K | Sell |
17,688
-12,638
| -42% | -$458K | 0.35% | 67 |
|
2020
Q4 | $1.12M | Sell |
30,326
-1,937
| -6% | -$71.3K | 0.64% | 30 |
|
2020
Q3 | $1.12M | Buy |
32,263
+1,295
| +4% | +$45.1K | 0.74% | 28 |
|
2020
Q2 | $961K | Sell |
30,968
-1,409
| -4% | -$43.7K | 0.7% | 29 |
|
2020
Q1 | $1M | Buy |
32,377
+299
| +0.9% | +$9.26K | 0.64% | 30 |
|
2019
Q4 | $1.19M | Buy |
32,078
+833
| +3% | +$31K | 0.53% | 36 |
|
2019
Q3 | $1.07M | Buy |
31,245
+6,513
| +26% | +$222K | 0.53% | 39 |
|
2019
Q2 | $1.02M | Buy |
24,732
+504
| +2% | +$20.7K | 0.54% | 36 |
|
2019
Q1 | $976K | Buy |
24,228
+12,424
| +105% | +$500K | 0.55% | 36 |
|
2018
Q4 | $489K | Buy |
+11,804
| New | +$489K | 0.36% | 54 |
|